The companies will join their respective technologies to offer customers a single solution for next-generation sequencing data interpretation.
The company also extended its existing licensing agreement with Genalice, signed in 2013, to improve plant DNA analysis.
The companies began working together in 2012 to validate the read alignment and variant calling technology for use in plant genomics.
Besides optimizing open-source code, the company has forged focused partnerships with multiple bioinformatics firms including Edico Genome and Curoverse.
Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.
By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.
Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.
In Nature this week: a Danish reference genome, and more.